Related ESCRT-III Subunit CHMP2B

Total Page:16

File Type:pdf, Size:1020Kb

Related ESCRT-III Subunit CHMP2B The Journal of Neuroscience, February 18, 2015 • 35(7):3155–3173 • 3155 Cellular/Molecular Regulation of Postsynaptic Function by the Dementia- Related ESCRT-III Subunit CHMP2B X Romain Chassefeyre,1,2* Jose´ Martínez-Herna´ndez,1,2* Federica Bertaso,3,4,5 Nathalie Bouquier,3,4,5 Be´atrice Blot,1,2 Marine Laporte,1,2 Sandrine Fraboulet,1,2 Yohann Coute´,6,7 Anny Devoy,8 Adrian M. Isaacs,8 Karin Pernet-Gallay,1,2 Re´my Sadoul,1,2 XLaurent Fagni,3,4,5 and Yves Goldberg1,2,9 1Institut National de la Sante´ et de la Recherche Me´dicale (INSERM), Unite´ 836, F-38042 Grenoble, France, 2Universite´ Grenoble Alpes, Grenoble Institut des Neurosciences (GIN), F-38042 Grenoble, France, 3CNRS, UMR-5203, Institut de Ge´nomique Fonctionnelle, F-34094 Montpellier, France, 4Universite´s de Montpellier 1 & 2, UMR-5203, F-34094 Montpellier, France, 5INSERM, Unite´ 661, F-34094 Montpellier, France, 6INSERM, Unite´ 1038, F-38054 Grenoble, France, 7Commissariat a` l’Energie Atomique (CEA), Institut de Recherches en Technologies et Sciences pour le Vivant (iRTSV), Laboratoire de Biologie a` Grande Echelle, F-38054 Grenoble, France, 8Department of Neurodegenerative Disease, University College London Institute of Neurology, London WC1N 3BG, United Kingdom, and 9CEA, iRTSV, Groupe Physiopathologie du Cytosquelette (GPC), F-38054 Grenoble, France The charged multivesicular body proteins (Chmp1–7) are an evolutionarily conserved family of cytosolic proteins that transiently assembles into helical polymers that change the curvature of cellular membrane domains. Mutations in human CHMP2B cause fronto- temporal dementia, suggesting that this protein may normally control some neuron-specific process. Here, we examined the function, localization, and interactions of neuronal Chmp2b. The protein was highly expressed in mouse brain and could be readily detected in neuronal dendrites and spines. Depletion of endogenous Chmp2b reduced dendritic branching of cultured hippocampal neurons, de- creased excitatory synapse density in vitro and in vivo, and abolished activity-induced spine enlargement and synaptic potentiation. To understand the synaptic effects of Chmp2b, we determined its ultrastructural distribution by quantitative immuno-electron microscopy and its biochemical interactions by coimmunoprecipitation and mass spectrometry. In the hippocampus in situ, a subset of neuronal Chmp2b was shown to concentrate beneath the perisynaptic membrane of dendritic spines. In synaptoneurosome lysates, Chmp2b was stably bound to a large complex containing other members of the Chmp family, as well as postsynaptic scaffolds. The supramolecular Chmp assembly detected here corresponds to a stable form of the endosomal sorting complex required for transport-III (ESCRT-III), a ubiquitous cytoplasmic protein complex known to play a central role in remodeling of lipid membranes. We conclude that Chmp2b- containing ESCRT-III complexes are also present at dendritic spines, where they regulate synaptic plasticity. We propose that synaptic ESCRT-III filaments may function as a novel element of the submembrane cytoskeleton of spines. Key words: ESCRT filaments; frontotemporal dementia; postsynaptic scaffold; spinoskeleton; structural plasticity Introduction cellular membrane remodeling during inward vesiculation of The endosomal sorting complex required for transport-III multivesicular endosomes, mitotic cell abscission, and viral bud- (ESCRT-III) is a ubiquitous protein complex that is crucial to ding (for review, see Henne et al., 2013; McCullough et al., 2013). The core subunits of ESCRT-III are a family of evolutionarily conserved proteins, called charged multivesicular body proteins Received Feb. 10, 2014; revised Dec. 23, 2014; accepted Jan. 6, 2015. Author contributions: R.S., L.F., and Y.G. designed research; R.C., J.M.-H., F.B., N.B., B.B., M.L., S.F., Y.C., A.D., (Chmp1-7). Dominant mutations in subunit CHMP2B cause A.M.I., K.P.-G., and Y.G. performed research; Y.C. and A.M.I. contributed unpublished reagents/analytic tools; R.C., frontotemporal dementia (FTD; Skibinski et al., 2005; Isaacs et J.M.-H., F.B., N.B., Y.C., K.P.-G., R.S., L.F., and Y.G. analyzed data; R.C., J.M.-H., A.M.I., R.S., L.F., and Y.G. wrote the al., 2011), raising the question whether some neuron-specific paper. process is controlled by this protein. Chmp2b and other ESCRT- This work was supported by a grant from the Agence Nationale de la Recherche (ANR), MALZ program, III subunits exist in the cytosol in a monomeric, autoinhibited France. R.C. and M.L. were supported by the Ministe`re de l’Enseignement Supe´rieur et de la Recherche, France. J.M.-H. and N.B. were supported by ANR. A.M.I. was supported by the United Kingdom Medical state. After release of intramolecular inhibition, individual sub- Research Council. We thank Y. Saoudi for help with microscopy and N. Jaafari, A. Petiot, and W. Weissenhorn units polymerize into circular or helical filaments (20–200 nm for critically reading this manuscript. wide, subject to subunit species) that adhere to lipid membranes *R.C. and J.M.-H. contributed equally to this work. and change their curvature (Shim et al., 2007; Hanson et al., 2008; The authors declare no competing financial interests. This article is freely available online through the J Neurosci Author Open Choice option. Lata et al., 2008; Bajorek et al., 2009; Henne et al., 2012; Buchk- Correspondence should be addressed to either Yves Goldberg or Rémy Sadoul,, Institut des Neurosciences, UJF ovich et al., 2013). Site Sante´, Chemin Ferrini, 38042 Grenoble cedex 9, France. E-mail: [email protected] or [email protected]. R. Chassefeyre’s present address: The Scripps Research Institute, La Jolla, CA 92037. This is an Open Access article distributed under the terms of the Creative Commons Attribution License DOI:10.1523/JNEUROSCI.0586-14.2015 (http://creativecommons.org/licenses/by/3.0),whichpermitsunrestricteduse,distributionandreproductioninany Copyright © 2015 Chassefeyre et al. medium provided that the original work is properly attributed. 3156 • J. Neurosci., February 18, 2015 • 35(7):3155–3173 Chassefeyre, Martínez-Herna´ndez et al. • ESCRT-III Function at Synapses Table 1. Plasmids used in this study Plasmid name Cloning technique Cloning sites Feature Tags Source pIRES2-EGFP Starting vector Clontech pIRES2-EGFP-CHMP2B WT In-Fusion (Clontech) XhoI, XhoI RNAi res. C-terminal FLAG This study pBI-CMV3 Starting vector Clontech pBI-CMV3-CHMP2B WT In-Fusion (Clontech) BamHI, HindIII RNAi res. This study pBI-CMV3-CHMP2B R19/22/26A In-Fusion (Clontech) BamHI, HindIII RNAi res. This study pBI-CMV3-CHMP2B L4D/F5D In-Fusion (Clontech) BamHI, HindIII RNAi res. This study pBI-CMV3-CHMP2B L207D/L210D In-Fusion (Clontech) BamHI, HindIII RNAi res. This study pSuper-mCherry Starting vector Belly et al., 2010 pSuper-mCherry shRNA vs CHMP2B Standard ligation HindIII, BglII Belly et al., 2010 pSuper-mCherry shRNA vs GFP Standard ligation HindIII, BglII This study pCDNA3.1-CHMP2B WT Topo (Invitrogen) C-terminal HA This study pCDNA3.1-CHMP2B R19/22/26A Topo (Invitrogen) C-terminal HA This study pCDNA3.1-CHMP4B Topo (Invitrogen) C-terminal FLAG Bodon et al., 2011 The cloning technique used to construct each plasmid and, if applicable, the associated kit supplier are indicated. RNAi res. Indicates the encoded mRNA is resistant to RNAi by the Chmp2b shRNA. We have previously shown that Chmp2b preferentially po- pSuper-mCherry. cDNAs encoding wild-type (WT) or mutant ver- lymerizes under the plasma membrane and, when overexpressed, sions of the RNAi-resistant Chmp2b (Belly et al., 2010) were cloned in organizes into helices that deform patches of the cell surface into the pBI-CMV3 vector (Clontech), yielding pBI-CMV3-Chmp2b WT, R19/22/26A L4D/F5D long protrusions (Bodon et al., 2011). Holomeric ESCRT-III pBI-CMV3-Chmp2b , and pBI-CMV3-Chmp2b .In consists of heteropolymeric Chmp filaments assembled at sites of these vectors, Chmp2b is coexpressed with fluorescent protein ZsGreen endosomal or plasma membrane deformation, after recruitment by from a bidirectional promoter. cDNA encoding wild-type, RNAi- resistant Chmp2b (carrying a single C-terminal Flag tag; Bodon et al., the upstream-acting complexes ESCRT-I and -II and/or by the 2011) was inserted upstream of the IRES sequence of the pIRES2-EGFP Chmp4b-binding protein Alix. ESCRT-III assemblies at membranes vector (Clontech), yielding pIRES2-EGFP-Chmp2b (used in Fig. 6B). In are thought to be transient, being dissociated after interaction with this vector, Chmp2b is coexpressed with EGFP from a bicistronic tran- the depolymerizing ATPase Vps4. This depolymerization step is script. All constructs were verified by sequencing (Beckman Coulter). coupled to scission of membrane necks modeled by ESCRT-III fila- Antibodies. See Table 2 for details of antibodies and dilutions. ments (Henne et al., 2013). Animals. Animals were handled and killed in conformity with Euro- FTD-associated CHMP2B mutants are deregulated and form pean law and internal regulations of INSERM. Pregnant Oncins France aberrant polymeric structures in transfected cells (Skibinski et al., souche A (OFA; a substrain of Sprague Dawley) rats (Charles River) were 2005). Strong expression of such a CHMP2B mutant in cultured used for primary neuron cultures, and 2-month-old OFA rats of both cortical neurons is rapidly lethal (Lee et al., 2007), and transgenic sexes were used for biochemical analysis of brain tissue. The rats were mice expressing the same mutant throughout their brain display deeply anesthetized by isoflurane inhalation before decapitation, quickly progressive neurodegenerative changes (Ghazi-Noori et al., followed by cesarean section or brain dissection. Three-month-old male 2012). These effects have been linked to defects in autophagic and C57BL/6 mice and 1.3-month-old female Chmp2b KO mice (here called KD mice since knock-out is incomplete; Ghazi-Noori et al., 2012)or endosomal degradation pathways (Filimonenko et al., 2007; Lee female WT littermates (on C57BL/6 background) were used for immu- et al., 2007; Urwin et al., 2010).
Recommended publications
  • Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights Into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle
    animals Article Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle Masoumeh Naserkheil 1 , Abolfazl Bahrami 1 , Deukhwan Lee 2,* and Hossein Mehrban 3 1 Department of Animal Science, University College of Agriculture and Natural Resources, University of Tehran, Karaj 77871-31587, Iran; [email protected] (M.N.); [email protected] (A.B.) 2 Department of Animal Life and Environment Sciences, Hankyong National University, Jungang-ro 327, Anseong-si, Gyeonggi-do 17579, Korea 3 Department of Animal Science, Shahrekord University, Shahrekord 88186-34141, Iran; [email protected] * Correspondence: [email protected]; Tel.: +82-31-670-5091 Received: 25 August 2020; Accepted: 6 October 2020; Published: 9 October 2020 Simple Summary: Hanwoo is an indigenous cattle breed in Korea and popular for meat production owing to its rapid growth and high-quality meat. Its yearling weight and carcass traits (backfat thickness, carcass weight, eye muscle area, and marbling score) are economically important for the selection of young and proven bulls. In recent decades, the advent of high throughput genotyping technologies has made it possible to perform genome-wide association studies (GWAS) for the detection of genomic regions associated with traits of economic interest in different species. In this study, we conducted a weighted single-step genome-wide association study which combines all genotypes, phenotypes and pedigree data in one step (ssGBLUP). It allows for the use of all SNPs simultaneously along with all phenotypes from genotyped and ungenotyped animals. Our results revealed 33 relevant genomic regions related to the traits of interest.
    [Show full text]
  • Genetic, Cytogenetic and Physical Refinement of the Autosomal Recessive CMT Linked to 5Q31ð Q33: Exclusion of Candidate Genes I
    European Journal of Human Genetics (1999) 7, 849–859 © 1999 Stockton Press All rights reserved 1018–4813/99 $15.00 t http://www.stockton-press.co.uk/ejhg ARTICLE Genetic, cytogenetic and physical refinement of the autosomal recessive CMT linked to 5q31–q33: exclusion of candidate genes including EGR1 Ang`ele Guilbot1, Nicole Ravis´e1, Ahmed Bouhouche6, Philippe Coullin4, Nazha Birouk6, Thierry Maisonobe3, Thierry Kuntzer7, Christophe Vial8, Djamel Grid5, Alexis Brice1,2 and Eric LeGuern1,2 1INSERM U289, 2F´ed´eration de Neurologie and 3Laboratoire de Neuropathologie R Escourolle, Hˆopital de la Salpˆetri`ere, Paris 4Laboratoire de cytog´en´etique, Villejuif 5G´en´ethon, Evry, France 6Service de Neurologie, Hˆopital des Sp´ecialit´es, Rabat, Morocco 7Service de Neurologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland 8Service D’EMG et de pathologie neuromusculaire, Hˆopital neurologique Pierre Wertheimer, Lyon, France Charcot-Marie-Tooth disease is an heterogeneous group of inherited peripheral motor and sensory neuropathies with several modes of inheritance: autosomal dominant, X-linked and autosomal recessive. By homozygosity mapping, we have identified, in the 5q23–q33 region, a third locus responsible for an autosomal recessive form of demyelinating CMT. Haplotype reconstruction and determination of the minimal region of homozygosity restricted the candidate region to a 4 cM interval. A physical map of the candidate region was established by screening YACs for microsatellites used for genetic analysis. Combined genetic, cytogenetic and physical mapping restricted the locus to a less than 2 Mb interval on chromosome 5q32. Seventeen consanguineous families with demyelinating ARCMT of various origins were screened for linkage to 5q31–q33.
    [Show full text]
  • In This Table Protein Name, Uniprot Code, Gene Name P-Value
    Supplementary Table S1: In this table protein name, uniprot code, gene name p-value and Fold change (FC) for each comparison are shown, for 299 of the 301 significantly regulated proteins found in both comparisons (p-value<0.01, fold change (FC) >+/-0.37) ALS versus control and FTLD-U versus control. Two uncharacterized proteins have been excluded from this list Protein name Uniprot Gene name p value FC FTLD-U p value FC ALS FTLD-U ALS Cytochrome b-c1 complex P14927 UQCRB 1.534E-03 -1.591E+00 6.005E-04 -1.639E+00 subunit 7 NADH dehydrogenase O95182 NDUFA7 4.127E-04 -9.471E-01 3.467E-05 -1.643E+00 [ubiquinone] 1 alpha subcomplex subunit 7 NADH dehydrogenase O43678 NDUFA2 3.230E-04 -9.145E-01 2.113E-04 -1.450E+00 [ubiquinone] 1 alpha subcomplex subunit 2 NADH dehydrogenase O43920 NDUFS5 1.769E-04 -8.829E-01 3.235E-05 -1.007E+00 [ubiquinone] iron-sulfur protein 5 ARF GTPase-activating A0A0C4DGN6 GIT1 1.306E-03 -8.810E-01 1.115E-03 -7.228E-01 protein GIT1 Methylglutaconyl-CoA Q13825 AUH 6.097E-04 -7.666E-01 5.619E-06 -1.178E+00 hydratase, mitochondrial ADP/ATP translocase 1 P12235 SLC25A4 6.068E-03 -6.095E-01 3.595E-04 -1.011E+00 MIC J3QTA6 CHCHD6 1.090E-04 -5.913E-01 2.124E-03 -5.948E-01 MIC J3QTA6 CHCHD6 1.090E-04 -5.913E-01 2.124E-03 -5.948E-01 Protein kinase C and casein Q9BY11 PACSIN1 3.837E-03 -5.863E-01 3.680E-06 -1.824E+00 kinase substrate in neurons protein 1 Tubulin polymerization- O94811 TPPP 6.466E-03 -5.755E-01 6.943E-06 -1.169E+00 promoting protein MIC C9JRZ6 CHCHD3 2.912E-02 -6.187E-01 2.195E-03 -9.781E-01 Mitochondrial 2-
    [Show full text]
  • DBN1 Monoclonal Antibody (M03), Clone 2E11
    DBN1 monoclonal antibody (M03), clone 2E11 Catalog # : H00001627-M03 規格 : [ 100 ug ] List All Specification Application Image Product Mouse monoclonal antibody raised against a full-length recombinant Western Blot (Recombinant protein) Description: DBN1. Sandwich ELISA (Recombinant Immunogen: DBN1 (AAH00283, 1 a.a. ~ 649 a.a) full-length recombinant protein with protein) GST tag. MW of the GST tag alone is 26 KDa. Sequence: MAGVSFSGHRLELLAAYEEVIREESAADWALYTYEDGSDDLKLAASGEG GLQELSGHFENQKVMYGFCSVKDSQAALPKYVLINWVGEDVPDARKCA CASHVAKVAEFFQGVDVIVNASSVEDIDAGAIGQRLSNGLARLSSPVLHR LRLREDENAEPVGTTYQKTDAAVEMKRINREQFWEQAKKEEELRKEEER KKALDERLRFEQERMEQERQEQEERERRYREREQQIEEHRRKQQTLEA enlarge EEAKRRLKEQSIFGDHRDEEEETHMKKSESEVEEAAAIIAQRPDNPREFF KQQERVASASAGSCDVPSPFNHRPGSHLDSHRRMAPTPIPTRSPSDSST ELISA ASTPVAEQIERALDEVTSSQPPPLPPPPPPAQETQEPSPILDSEETRAAA PQAWAGPMEEPPQAQAPPRGPGSPAEDLMFMESAEQAVLAAPVEPAT ADATEVHDAADTIETDTATADTTVANNVPPAATSLIDLWPGNGEGASTLQ GEPRAPTPPSGTEVTLAEVPLLDEVAPEPLLPAGEGCATLLNFDELPEPP ATFCDPEEVEGEPLAAPQTPTLPSALEELEQEQEPEPHLLTNGETTQKE GTQASEGYFSQSQEEEFAQSEELCAKAPPPVFYNKPPEIDITCWDADPV PEEEEGFEGGD Host: Mouse Reactivity: Human Isotype: IgG2a Kappa Quality Control Antibody Reactive Against Recombinant Protein. Testing: Western Blot detection against Immunogen (97.13 KDa) . Storage Buffer: In 1x PBS, pH 7.4 Storage Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. Instruction: MSDS: Download Datasheet: Download Applications Page 1 of 2 2016/5/20 Western Blot (Recombinant protein) Protocol Download Sandwich ELISA (Recombinant
    [Show full text]
  • A Master Autoantigen-Ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases
    bioRxiv preprint doi: https://doi.org/10.1101/2021.07.30.454526; this version posted August 4, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases Julia Y. Wang1*, Michael W. Roehrl1, Victor B. Roehrl1, and Michael H. Roehrl2* 1 Curandis, New York, USA 2 Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA * Correspondence: [email protected] or [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.07.30.454526; this version posted August 4, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Abstract Chronic and debilitating autoimmune sequelae pose a grave concern for the post-COVID-19 pandemic era. Based on our discovery that the glycosaminoglycan dermatan sulfate (DS) displays peculiar affinity to apoptotic cells and autoantigens (autoAgs) and that DS-autoAg complexes cooperatively stimulate autoreactive B1 cell responses, we compiled a database of 751 candidate autoAgs from six human cell types. At least 657 of these have been found to be affected by SARS-CoV-2 infection based on currently available multi-omic COVID data, and at least 400 are confirmed targets of autoantibodies in a wide array of autoimmune diseases and cancer.
    [Show full text]
  • Transdifferentiation of Human Mesenchymal Stem Cells
    Transdifferentiation of Human Mesenchymal Stem Cells Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Julius-Maximilians-Universität Würzburg vorgelegt von Tatjana Schilling aus San Miguel de Tucuman, Argentinien Würzburg, 2007 Eingereicht am: Mitglieder der Promotionskommission: Vorsitzender: Prof. Dr. Martin J. Müller Gutachter: PD Dr. Norbert Schütze Gutachter: Prof. Dr. Georg Krohne Tag des Promotionskolloquiums: Doktorurkunde ausgehändigt am: Hiermit erkläre ich ehrenwörtlich, dass ich die vorliegende Dissertation selbstständig angefertigt und keine anderen als die von mir angegebenen Hilfsmittel und Quellen verwendet habe. Des Weiteren erkläre ich, dass diese Arbeit weder in gleicher noch in ähnlicher Form in einem Prüfungsverfahren vorgelegen hat und ich noch keinen Promotionsversuch unternommen habe. Gerbrunn, 4. Mai 2007 Tatjana Schilling Table of contents i Table of contents 1 Summary ........................................................................................................................ 1 1.1 Summary.................................................................................................................... 1 1.2 Zusammenfassung..................................................................................................... 2 2 Introduction.................................................................................................................... 4 2.1 Osteoporosis and the fatty degeneration of the bone marrow..................................... 4 2.2 Adipose and bone
    [Show full text]
  • Functional Genomic Annotation of Genetic Risk Loci Highlights Inflammation and Epithelial Biology Networks in CKD
    BASIC RESEARCH www.jasn.org Functional Genomic Annotation of Genetic Risk Loci Highlights Inflammation and Epithelial Biology Networks in CKD Nora Ledo, Yi-An Ko, Ae-Seo Deok Park, Hyun-Mi Kang, Sang-Youb Han, Peter Choi, and Katalin Susztak Renal Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania ABSTRACT Genome-wide association studies (GWASs) have identified multiple loci associated with the risk of CKD. Almost all risk variants are localized to the noncoding region of the genome; therefore, the role of these variants in CKD development is largely unknown. We hypothesized that polymorphisms alter transcription factor binding, thereby influencing the expression of nearby genes. Here, we examined the regulation of transcripts in the vicinity of CKD-associated polymorphisms in control and diseased human kidney samples and used systems biology approaches to identify potentially causal genes for prioritization. We interro- gated the expression and regulation of 226 transcripts in the vicinity of 44 single nucleotide polymorphisms using RNA sequencing and gene expression arrays from 95 microdissected control and diseased tubule samples and 51 glomerular samples. Gene expression analysis from 41 tubule samples served for external validation. 92 transcripts in the tubule compartment and 34 transcripts in glomeruli showed statistically significant correlation with eGFR. Many novel genes, including ACSM2A/2B, FAM47E, and PLXDC1, were identified. We observed that the expression of multiple genes in the vicinity of any single CKD risk allele correlated with renal function, potentially indicating that genetic variants influence multiple transcripts. Network analysis of GFR-correlating transcripts highlighted two major clusters; a positive correlation with epithelial and vascular functions and an inverse correlation with inflammatory gene cluster.
    [Show full text]
  • Datasheet: VPA00848 Product Details
    Datasheet: VPA00848 Description: RABBIT ANTI DREBRIN 1 Specificity: DREBRIN 1 Format: Purified Product Type: PrecisionAb™ Polyclonal Isotype: Polyclonal IgG Quantity: 100 µl Product Details Applications This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit www.bio-rad-antibodies.com/protocols. Yes No Not Determined Suggested Dilution Western Blotting 1/1000 PrecisionAb antibodies have been extensively validated for the western blot application. The antibody has been validated at the suggested dilution. Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Further optimization may be required dependant on sample type. Target Species Human Product Form Purified IgG - liquid Preparation Rabbit polyclonal antibody purified by affinity chromatography on immunogen Buffer Solution Phosphate buffered saline Preservative 0.09% Sodium Azide Stabilisers Immunogen KLH conjugated synthetic peptide corresponding to amino acids 1-28 of human drebrin 1 External Database Links UniProt: Q16643 Related reagents Entrez Gene: 1627 DBN1 Related reagents Synonyms D0S117E Specificity Rabbit anti Human drebrin 1 antibody recognizes drebrin 1, also known as developmentally- regulated brain protein-drebrin, drebrin E, DBN1 and drebrin E2. The protein encoded by DBN1 is a cytoplasmic actin-binding protein thought to play a role in the Page 1 of 2 process of neuronal growth. It is a member of the drebrin family of proteins that are developmentally regulated in the brain.
    [Show full text]
  • S-Palmitoylation of Synaptic Proteins As a Novel Mechanism Underlying Sex-Dependent Differences in Neuronal Plasticity
    International Journal of Molecular Sciences Article S-Palmitoylation of Synaptic Proteins as a Novel Mechanism Underlying Sex-Dependent Differences in Neuronal Plasticity Monika Zar˛eba-Kozioł 1,*,† , Anna Bartkowiak-Kaczmarek 1,†, Matylda Roszkowska 1, Krystian Bijata 1,2, Izabela Figiel 1 , Anup Kumar Halder 3 , Paulina Kami ´nska 1, Franziska E. Müller 4, Subhadip Basu 3 , Weiqi Zhang 5, Evgeni Ponimaskin 4 and Jakub Włodarczyk 1,* 1 Laboratory of Cell Biophysics, Nencki Institute of Experimental Biology, Polish Academy of Science, Pasteur Str. 3, 02-093 Warsaw, Poland; [email protected] (A.B.-K.); [email protected] (M.R.); [email protected] (K.B.); i.fi[email protected] (I.F.); [email protected] (P.K.) 2 Faculty of Chemistry, University of Warsaw, Pasteura 1, 02-093 Warsaw, Poland 3 Department of Computer Science and Engineering, Jadvapur University, Kolkata 700032, India; [email protected] (A.K.H.); [email protected] (S.B.) 4 Cellular Neurophysiology, Hannover Medical School, Carl-Neuberg Str. 1, 30625 Hannover, Germany; [email protected] (F.E.M.); [email protected] (E.P.) 5 Department of Mental Health, University of Münster, Albert-Schweitzer-Campus 1/A9, 48149 Munster, Germany; [email protected] * Correspondence: [email protected] (M.Z.-K.); [email protected] (J.W.) † These authors contributed equally. Abstract: Although sex differences in the brain are prevalent, the knowledge about mechanisms Citation: Zar˛eba-Kozioł,M.; underlying sex-related effects on normal and pathological brain functioning is rather poor. It is Bartkowiak-Kaczmarek, A.; known that female and male brains differ in size and connectivity.
    [Show full text]
  • A CRISPR Screen to Identify Combination Therapies of Cytotoxic
    CRISPRi Screens to Identify Combination Therapies for the Improved Treatment of Ovarian Cancer By Erika Daphne Handly B.S. Chemical Engineering Brigham Young University, 2014 Submitted to the Department of Biological Engineering in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biological Engineering at the MASSACHUSETTS INSTITUTE OF TECHNOLOGY February 2021 © 2020 Massachusetts Institute of Technology. All rights reserved. Signature of author………………………………………………………………………………… Erika Handly Department of Biological Engineering February 2021 Certified by………………………………………………………………………………………… Michael Yaffe Director MIT Center for Precision Cancer Medicine Department of Biological Engineering and Biology Thesis Supervisor Accepted by………………………………………………………………………………………... Katharina Ribbeck Professor of Biological Engineering Chair of Graduate Program, Department of Biological Engineering Thesis Committee members Michael T. Hemann, Ph.D. Associate Professor of Biology Massachusetts Institute of Technology Douglas A. Lauffenburger, Ph.D. (Chair) Ford Professor of Biological Engineering, Chemical Engineering, and Biology Massachusetts Institute of Technology Michael B. Yaffe, M.D., Ph.D. (Thesis Supervisor) David H. Koch Professor of Science Prof. of Biology and Biological Engineering Massachusetts Institute of Technology 2 CRISPRi Screens to Identify Combination Therapies for the Improved Treatment of Ovarian Cancer By Erika Daphne Handly B.S. Chemical Engineering Brigham Young University, 2014 Submitted to the Department of Biological Engineering in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biological Engineering ABSTRACT Ovarian cancer is the fifth leading cause of cancer death for women in the United States, with only modest improvements in patient survival in the past few decades. Standard-of-care consists of surgical debulking followed by a combination of platinum and taxane agents, but relapse and resistance frequently occur.
    [Show full text]
  • Developmental Retardation Due to Paternal 5Q/11Q Translocation in a Chinese Infant: Clinical, Chromosomal and Microarray Characterization
    Journal of Genetics (2019) 98:77 © Indian Academy of Sciences https://doi.org/10.1007/s12041-019-1120-3 RESEARCH ARTICLE Developmental retardation due to paternal 5q/11q translocation in a Chinese infant: clinical, chromosomal and microarray characterization XIANGYU ZHAO1 , HONGYAN XU1, CHEN ZHAO2 and LIN LI1∗ 1Department of Medical Genetics, Linyi People’s Hospital, Linyi 276003, Shandong, People’s Republic of China 2Department of Neurology, Weifang People’s Hospital, Weifang 261000, Shandong, People’s Republic of China *For correspondence. E-mail: [email protected]. Received 12 June 2018; revised 18 April 2019; accepted 19 May 2019 Abstract. Although it is known that the parental carriers of chromosomal translocation are considered to be at high risk for spontaneous abortion and embryonic death, normal gestation and delivery remain possible. This study aims to investigate the genetic factors of a Chinese infant with multiple malformations and severe postnatal development retardation. In this study, the routine cytogenetic analysis, chromosomal microarray analysis (CMA) and fluorescence in situ hybridization (FISH) analysis were performed. Conventional karyotype analyses revealed normal karyotypes of all family members. CMA of the DNA of the proband revealed a 8.3 Mb duplication of 5q35.1-qter and a 6.9 Mb deletion of 11q24.3-qter. FISH analyses verified a paternal tiny translocation between the long arm of chromosomes 5 and 11. Our investigation serves to provide important information on genetic counselling for the patient and future pregnancies in this family. Moreover, the combined use of CMA and FISH is effective for clarifying pathogenically submicroscopic copy number variants. Keywords. 5q/11q translocation; karyotyping; chromosomal microarray analysis; fluorescence in situ hybridization; growth retardation.
    [Show full text]
  • Exploratory Neuroimmune Profiling Identifies CNS-Specific Alterations in COVID-19 Patients with Neurological Involvement
    bioRxiv preprint doi: https://doi.org/10.1101/2020.09.11.293464; this version posted December 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Exploratory neuroimmune profiling identifies CNS-specific alterations in COVID-19 patients with neurological involvement Authors: Eric Song1,†,*, Christopher M. Bartley2,3,4†, Ryan D. Chow5, Thomas T. Ngo3,4, Ruoyi Jiang1, Colin R. Zamecnik3,6, Ravi Dandekar3,6, Rita P. Loudermilk3,6, Yile Dai1, Feimei Liu1, Isobel A. Hawes3,6,7, Bonny D. Alvarenga3,6, Trung Huynh3,6, Lindsay McAlpine8, Nur-Taz Rahman9, Bertie Geng10, Jennifer Chiarella8, Benjamin Goldman-Israelow1,9, Chantal B.F. Vogels11, Nathan D. Grubaugh11, Arnau Casanovas-Massana11, Brett S. Phinney12, Michelle Salemi12, Jessa Alexander3,6, Juan A. Gallego13-15, Todd Lencz13-15, Hannah Walsh9, Carolina Lucas1, Jon Klein1, Tianyang Mao1, Jieun Oh1, Aaron Ring1, Serena Spudich8, Albert I. Ko10,11, Steven H. Kleinstein1,16,17, Joseph L. DeRisi18,19, Akiko Iwasaki1,20,21, Samuel J. Pleasure3,6,b Michael R. Wilson3,6, ‡,*, Shelli F. Farhadian8,10, ‡,* Affiliations: 1 Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA. 2 Hanna H. Gray Fellow, Howard Hughes Medical Institute, Chevy Chase, MD, USA. 3 Weill Institute for Neurosciences, University of California, San Francisco, CA, USA. 4 Department of Psychiatry, University of California, San Francisco, CA, USA. 5 Department of Genetics, Yale School of Medicine, New Haven, CT, USA.
    [Show full text]